MX2007007032A - Compuestos de aminopirimidina y metodos de uso. - Google Patents
Compuestos de aminopirimidina y metodos de uso.Info
- Publication number
- MX2007007032A MX2007007032A MX2007007032A MX2007007032A MX2007007032A MX 2007007032 A MX2007007032 A MX 2007007032A MX 2007007032 A MX2007007032 A MX 2007007032A MX 2007007032 A MX2007007032 A MX 2007007032A MX 2007007032 A MX2007007032 A MX 2007007032A
- Authority
- MX
- Mexico
- Prior art keywords
- aminopyrimidine compounds
- methods
- relates
- aminopyrimidine
- plk1
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La invencion se refiere a compuestos de aminopirimidina utiles para el tratamiento de enfermedades mediadas por cinasa 1 de tipo polo (Plkl). La invencion tambien se refiere al uso terapeutico de los compuestos de aminopirimidina y composiciones de la misma para el tratamiento de enfermedades asociadas con el crecimiento anormal de la celula y la proliferacion indeseada de la celula.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63660404P | 2004-12-17 | 2004-12-17 | |
PCT/US2005/045863 WO2006066172A1 (en) | 2004-12-17 | 2005-12-16 | Aminopyrimidine compounds and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007007032A true MX2007007032A (es) | 2007-07-04 |
Family
ID=36588221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007007032A MX2007007032A (es) | 2004-12-17 | 2005-12-16 | Compuestos de aminopirimidina y metodos de uso. |
Country Status (9)
Country | Link |
---|---|
US (2) | US7786132B2 (es) |
EP (1) | EP1831207B1 (es) |
JP (1) | JP4932735B2 (es) |
CN (1) | CN101115749B (es) |
AU (1) | AU2005316312B2 (es) |
CA (1) | CA2590939C (es) |
ES (1) | ES2397362T3 (es) |
MX (1) | MX2007007032A (es) |
WO (1) | WO2006066172A1 (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
TW200533357A (en) * | 2004-01-08 | 2005-10-16 | Millennium Pharm Inc | 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
DE102005048072A1 (de) * | 2005-09-24 | 2007-04-05 | Bayer Cropscience Ag | Thiazole als Fungizide |
TW200800201A (en) * | 2005-11-18 | 2008-01-01 | Lilly Co Eli | Pyrimidinyl benzothiophene compounds |
AU2006331656B2 (en) * | 2005-12-22 | 2012-08-09 | Icagen, Inc. | Calcium channel antagonists |
CA2637335A1 (en) | 2006-01-23 | 2007-08-02 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
CA2648207A1 (en) * | 2006-04-13 | 2007-10-25 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
WO2007139795A1 (en) | 2006-05-23 | 2007-12-06 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
EP2027116A2 (en) | 2006-05-23 | 2009-02-25 | Vertex Pharmaceuticals Incorporated | Thiophene-carboxamides useful as inhibitors of protein kinases |
CN100422331C (zh) * | 2006-06-28 | 2008-10-01 | 南京农业大学 | 一个簇毛麦丝氨酸/苏氨酸激酶基因及其所编码的蛋白质 |
JP2009544625A (ja) * | 2006-07-20 | 2009-12-17 | メーメット・カーラマン | Rhoキナーゼのベンゾチオフェン阻害剤 |
CN101568539B (zh) * | 2006-12-21 | 2012-04-25 | 伊莱利利公司 | 用于治疗癌症的咪唑啉酮基氨基嘧啶化合物 |
ATE479680T1 (de) | 2006-12-21 | 2010-09-15 | Lilly Co Eli | Imidazolidinonylaminopyrimidinverbindungen zur behandlung von krebs |
KR101475540B1 (ko) * | 2007-01-29 | 2014-12-22 | 산텐 세이야꾸 가부시키가이샤 | 혈관 신생 저해 활성을 갖는 신규 옥사디아졸 유도체 및 티아디아졸 유도체 |
WO2008144222A2 (en) * | 2007-05-16 | 2008-11-27 | Eli Lilly And Company | Triazolyl aminopyrimidine compounds |
WO2008144223A2 (en) * | 2007-05-16 | 2008-11-27 | Eli Lilly And Company | Triazolyl aminopyrimidine compounds |
KR20100092473A (ko) * | 2007-11-01 | 2010-08-20 | 액테리온 파마슈티칼 리미티드 | 신규한 피리미딘 유도체 |
EP2583557B1 (de) * | 2008-07-17 | 2016-01-13 | Bayer CropScience AG | Heterocyclische Verbindungen als Schädlingsbekämpfungsmittel |
WO2010068863A2 (en) | 2008-12-12 | 2010-06-17 | Cystic Fibrosis Foundation Therapeutics, Inc. | Pyrimidine compounds and methods of making and using same |
CN102439091A (zh) * | 2009-02-06 | 2012-05-02 | 国立大学法人北海道大学 | 荧光溶剂化变色色素 |
EP2501696B1 (en) * | 2009-10-15 | 2016-12-28 | Guerbet | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
EP2560488B1 (en) | 2010-04-23 | 2015-10-28 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
JP2013147428A (ja) * | 2010-04-27 | 2013-08-01 | Dainippon Sumitomo Pharma Co Ltd | 新規2−ヘテロアリール単環ピリミジン誘導体 |
US8334292B1 (en) | 2010-06-14 | 2012-12-18 | Cystic Fibrosis Foundation Therapeutics, Inc. | Pyrimidine compounds and methods of making and using same |
AU2013216935C1 (en) | 2012-02-08 | 2017-12-14 | John Emmerson Campbell | Heteroaryl compounds and methods of use thereof |
WO2015116696A1 (en) | 2014-01-28 | 2015-08-06 | Massachusetts Institute Of Technology | Combination therapies and methods of use thereof for treating cancer |
CN104860900A (zh) * | 2014-02-25 | 2015-08-26 | 中国药科大学 | 噻唑类化合物、其制备方法及其在制药中的用途 |
CN105884711A (zh) * | 2014-12-16 | 2016-08-24 | 中国药科大学 | 噻唑类化合物、其制备方法及其在制药中的用途 |
CN108138177B9 (zh) | 2015-07-23 | 2021-08-13 | 法国居里学院 | Dbait分子与PARP抑制剂的组合用于治疗癌症的用途 |
GB201519573D0 (en) | 2015-11-05 | 2015-12-23 | King S College London | Combination |
EP3390368A4 (en) * | 2015-12-17 | 2019-07-03 | ArQule, Inc. | PROCESS FOR PREPARING SUBSTITUTED 5,6-DIHYDRO-6-PHENYL BENZO [F] ISOCHINOLINE-2-AMINE |
MA45857A (fr) | 2016-07-29 | 2021-05-19 | Sunovion Pharmaceuticals Inc | Composés et compositions, et utilisations associées |
EP3490607A4 (en) | 2016-07-29 | 2020-04-08 | Sunovion Pharmaceuticals Inc. | COMPOUNDS AND COMPOSITIONS, AND USES THEREOF |
WO2018162439A1 (en) | 2017-03-08 | 2018-09-13 | Onxeo | New predictive biomarker for the sensitivity to a treatment of cancer with a dbait molecule |
JP7191085B2 (ja) | 2017-08-02 | 2022-12-16 | サノビオン ファーマシューティカルズ インク | イソクロマン化合物およびその使用 |
WO2019025250A1 (en) | 2017-08-04 | 2019-02-07 | Basf Se | SUBSTITUTED TRIFLUOROMETHYLOXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI |
US20200407720A1 (en) | 2018-03-13 | 2020-12-31 | Onxeo | A dbait molecule against acquired resistance in the treatment of cancer |
EP3938045A1 (en) | 2019-03-14 | 2022-01-19 | Sunovion Pharmaceuticals Inc. | Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
CN112125879A (zh) * | 2020-09-29 | 2020-12-25 | 浙江永太科技股份有限公司 | 一种卡格列净中间体2-(4-氟苯基)噻吩的制备方法 |
CN114133337A (zh) * | 2020-12-14 | 2022-03-04 | 成都泰蓉生物科技有限公司 | 一种2-取代的赖氨酸的制备方法 |
WO2022189191A1 (en) * | 2021-03-09 | 2022-09-15 | Basf Se | Tricyclic pesticidal compounds |
US20230263783A1 (en) | 2022-02-18 | 2023-08-24 | Massachusetts Institute Of Technology | Cancer treatment by combined inhibition of polo-like kinase and microtubule polymerization |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE135699T1 (de) | 1986-01-13 | 1996-04-15 | American Cyanamid Co | 4,5,6-substituierte 2-pyrimidinamine |
DE4025891A1 (de) | 1990-08-16 | 1992-02-20 | Bayer Ag | Pyrimidyl-substituierte acrylsaeureester |
US5543520A (en) | 1993-10-01 | 1996-08-06 | Ciba-Geigy Corporation | Pyrimidine derivatives |
GB9523675D0 (en) | 1995-11-20 | 1996-01-24 | Celltech Therapeutics Ltd | Chemical compounds |
US6417185B1 (en) | 1998-06-19 | 2002-07-09 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
KR20010086461A (ko) | 1998-12-24 | 2001-09-12 | 오흘러 로스 제이. | 인자 xa 억제제로서의 치환된 (아미노이미노메틸 또는아미노메틸)벤조헤테로아릴 화합물 |
SE9902987D0 (sv) | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
GB2361236B (en) | 2000-03-29 | 2002-04-24 | Cyclacel Ltd | Pyrimidines useful against proliferative disorders |
KR100860827B1 (ko) | 2000-09-06 | 2008-09-30 | 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 | 글리코겐 합성효소 키나아제 3의 억제제 |
MXPA03010961A (es) | 2001-05-31 | 2004-02-27 | Vertex Pharma | Compuestos de tiazol utiles como inhibidores de proteinas cinasas. |
DE60217140T2 (de) * | 2001-09-28 | 2007-04-19 | Cyclacel Ltd. | N-(4-(4-methylthiazol-5-yl)pyrimidin-2-yl)-n-phenylamine als antiproliferative verbindungen |
CN1649853A (zh) * | 2002-05-03 | 2005-08-03 | 舍林股份公司 | 噻唑烷酮类化合物、其制备方法以及作为药物的应用 |
US7361665B2 (en) * | 2002-07-09 | 2008-04-22 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
RU2296758C2 (ru) | 2002-08-08 | 2007-04-10 | Смитклайн Бичем Корпорейшн | Производные тиофена |
AU2003284399A1 (en) * | 2002-11-14 | 2004-06-03 | Kyowa Hakko Kogyo Co., Ltd. | Plk inhibitors |
GB0226583D0 (en) * | 2002-11-14 | 2002-12-18 | Cyclacel Ltd | Compounds |
TW200519106A (en) * | 2003-05-02 | 2005-06-16 | Novartis Ag | Organic compounds |
-
2005
- 2005-12-16 WO PCT/US2005/045863 patent/WO2006066172A1/en active Application Filing
- 2005-12-16 MX MX2007007032A patent/MX2007007032A/es active IP Right Grant
- 2005-12-16 US US11/304,901 patent/US7786132B2/en active Active
- 2005-12-16 EP EP05854551A patent/EP1831207B1/en active Active
- 2005-12-16 JP JP2007546989A patent/JP4932735B2/ja active Active
- 2005-12-16 AU AU2005316312A patent/AU2005316312B2/en active Active
- 2005-12-16 ES ES05854551T patent/ES2397362T3/es active Active
- 2005-12-16 CN CN2005800479087A patent/CN101115749B/zh active Active
- 2005-12-16 CA CA2590939A patent/CA2590939C/en active Active
-
2009
- 2009-09-18 US US12/562,853 patent/US7858785B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2008524248A (ja) | 2008-07-10 |
EP1831207B1 (en) | 2012-11-14 |
US7858785B2 (en) | 2010-12-28 |
AU2005316312B2 (en) | 2009-10-22 |
EP1831207A1 (en) | 2007-09-12 |
CN101115749A (zh) | 2008-01-30 |
EP1831207A4 (en) | 2010-09-15 |
CA2590939C (en) | 2011-10-18 |
AU2005316312A1 (en) | 2006-06-22 |
CA2590939A1 (en) | 2006-06-22 |
US20100010014A1 (en) | 2010-01-14 |
ES2397362T3 (es) | 2013-03-06 |
WO2006066172A1 (en) | 2006-06-22 |
US20070185133A1 (en) | 2007-08-09 |
US7786132B2 (en) | 2010-08-31 |
JP4932735B2 (ja) | 2012-05-16 |
CN101115749B (zh) | 2011-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007007032A (es) | Compuestos de aminopirimidina y metodos de uso. | |
MX2007004551A (es) | Compuestos tiadiazol y metodos de uso. | |
UA91895C2 (en) | Thiazole compounds and methods of use | |
HK1116349A1 (en) | Pyrrolopyrimidines useful as inhibitors of protein kinase | |
TW200630374A (en) | Thiazolyldihydroindazoles | |
MX337817B (es) | Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas. | |
SG151327A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
SG170828A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
TW200736249A (en) | Aminopyrimidines useful as kinase inhibitors | |
UA92355C2 (en) | urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS | |
TW200619218A (en) | Pyrimidines as PLK inhibitors | |
HK1096673A1 (en) | Compositions useful as inhibitors of protein kinases | |
AU2005253776A8 (en) | Screening methods using c-Abl, Fyn and Syk in combination with tau protein | |
MX2007014619A (es) | Pirrolopiridinas de utilidad como inhibidores de proteina quinasa. | |
MX2009006700A (es) | Derivados de 5-ciano-4-(pirolo)[2,3b]piridina-3-il)-pirimidinas utiles como inhibidores de proteina-cinasas. | |
TW200633980A (en) | Pyridones useful as inhibitors of kinases | |
ZA200702645B (en) | Diaminotriazole compounds useful as protein kinase inhibitors | |
ATE450530T1 (de) | Zusammensetzungen zur verwendung als protein- kinase-inhibitoren | |
MX2010006748A (es) | Pirazolo[1,5-a]pirimidinas utiles como inhibidores de jak2. | |
GEP20125565B (en) | Lactam compounds and their pharmaceutical use | |
TW200728305A (en) | Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease | |
GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
MX2009009591A (es) | Aminopirimidinas utiles como inhibidores de proteinas cinasas. | |
PT1635824E (pt) | Inibidores de p-38 à base de heterociclos de 5 membros | |
TW200509892A (en) | Novel aminobenzophenone compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |